PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-03-30
DOI
10.1038/srep09384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual-specificity phosphatases: critical regulators with diverse cellular targets
- (2015) Kate I. Patterson et al. BIOCHEMICAL JOURNAL
- The variability of autophagy and cell death susceptibility
- (2013) Ben Loos et al. Autophagy
- First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer
- (2013) Muhammad Wasif Saif et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Emerging regulation and functions of autophagy
- (2013) Patricia Boya et al. NATURE CELL BIOLOGY
- Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells
- (2013) W-T Tai et al. Cell Death & Disease
- Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy
- (2012) Sara Rockwell et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Old formula, new Rx: The journey of PHY906 as cancer adjuvant therapy
- (2012) Shwu-Huey Liu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment
- (2011) Ena Wang et al. BMC Medical Genomics
- A Phase I Study of the Chinese Herbal Medicine PHY906 as a Modulator of Irinotecan-based Chemotherapy in Patients with Advanced Colorectal Cancer
- (2011) Shivaani Kummar et al. Clinical Colorectal Cancer
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK
- (2011) L. Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS)
- (2010) Wei Zhang et al. JOURNAL OF CHROMATOGRAPHY A
- Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
- (2010) Margaret A. Park et al. MOLECULAR CANCER THERAPEUTICS
- Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies
- (2010) M. Wasif Saif et al. PHYTOMEDICINE
- Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
- (2010) D. F. Egan et al. SCIENCE
- The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity
- (2010) W. Lam et al. Science Translational Medicine
- A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqi Tang (HQT) and PHY906
- (2010) Robert Tilton et al. Chinese Medicine
- Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudy
- (2009) Zhe Zhang et al. BMC Medicine
- ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
- (2009) Sebastien Cagnol et al. FEBS Journal
- Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms
- (2009) T. Walker et al. MOLECULAR PHARMACOLOGY
- ERK and JNK mediate TNFα-induced p53 activation in apoptotic and autophagic L929 cell death
- (2008) Yan Cheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Involvement of miltefosine-mediated ERK activation in glioma cell apoptosis through Fas regulation
- (2008) Richa Tewari et al. JOURNAL OF NEUROCHEMISTRY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search